Answers are grounded in this paper and cite their sources.
Narrative review highlights critical translational challenges in acute ischemic stroke care, indicating key preclinical targets to improve patient outcomes.
Ischemic stroke research has enabled significant advancements in diagnosis, treatment, and management of this debilitating disease, yet challenges remain standing in the way of better patient prognoses.In this narrative review, a fictional case illustrates challenges and uncertainties that medical professionals still facepenumbra identification, lack of neuroprotective agents, side-effects of tissue plasminogen activator, dearth of molecular biomarkers, incomplete microvascular reperfusion or no-reflow, post-recanalization hyperperfusion, blood pressure management and procedural anesthetic effects.The current state of the field is broadly reviewed per topic, with the aim to introduce a broad audience (scientist and clinician alike) to recent successes in translational stroke research and pending scientific queries that are tractable for preclinical assessment.Opportunities for co-operation between clinical and experimental stroke experts are highlighted to increase the size and frequency of strides the field makes to improve our understanding of this disease and ways of treating it. The clinicIt is 9:30 in the morning.A seasoned vascular neurologist admits a patient to the ER of a large stroke-center.Evidently, the patienta 64year-old womanhas suffered a stroke.She was found laying next to her bed in the early morning, at 7:30, by her husband.She went to bed at 23:30, but last seen well by her husband at 6:00, and was still well at that time.No medication used.The patient is immediately brought to the CT area.ECG shows sinus rhythm.Vital signs are OK, blood pressure (BP) is 179/94 mm Hg and the patient has a left-sided hemianopia, facial weakness, hemiparesis, dysarthria a sensory deficit and left sided sensory neglect with a NIH Stroke Scale score of 19 (Brott et al., 1989).A CT, CTA and perfusion CT is ordered and immediately carried out.CT shows a large area with early ischemic change (ASPECTS 5) of the right hemisphere.CT angiography reveals an occlusion of the carotid top, with collaterals grade 2, and CT Perfusion shows a large core and penumbra (Fig. 1) (Barber et al., 2000).A diagnosis of ischemic stroke, likely of embolic origin, but of yet unknown source, is made.The interruption of blood flow at the level of the proximal middle cerebral artery clearly caused the symptoms.Immediately after the results of the plain CT scan have been obtained, a thrombolytic (tenecteplase) is being given intravenously at a single dose of 0.25 mg/kg.Directly after starting thrombolytics the patient is transferred to the angio-suite for endovascular treatment (EVT).A catheter is introduced into the femoral artery, and advanced up to the site of occlusion, after which removal of the occluding thrombus with a stent retriever and aspiration is attempted.During the procedure systolic BP increases to 220/125, and analgesics and slight sedation with continuous infusion of midazolam is being given.After two attempts, the thrombo-embolus is extracted and a TICI grade 3 is reached.The thrombo-embolus comes out fragmented and partly aspirated, macroscopically it seems to consist of red blood cells but also of a yellowish substance.The patient is then transferred to a high care stroke unit.After 24 h, the patient is still not able to speak well because of dysarthria, and she has a right sided hemianopia, mild right hemiparesis of face and extremities and NIHSS has slightly improved to 16.
No takes yet. Share an insight, caveat, or question.
Franx et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: